The PURA gene mental retardation autosomal dominant type 31 genetic test is a specialized diagnostic procedure designed to identify mutations in the PURA gene, which have been associated with a rare form of intellectual disability known as mental retardation, autosomal dominant type 31. This condition is characterized by developmental delays, intellectual challenges, and in some cases, physical abnormalities and neurological issues. The test is crucial for early diagnosis, which can significantly aid in the management and treatment of the condition, potentially improving the quality of life for those affected.
Performed at DNA Labs UAE, a leading genetic testing facility, this test offers a comprehensive analysis of the PURA gene to detect any abnormalities that may indicate the presence of the disorder. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to conduct such a specialized genetic analysis. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect high-quality services, accurate results, and the support needed to understand and manage the implications of the findings.
The "MBD5 Gene Mental Retardation Autosomal Dominant Type 1 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the MBD5 gene, which are linked to mental retardation autosomal dominant type 1 (MRD1). This condition is characterized by various degrees of intellectual disability, potential developmental delays, and sometimes accompanying physical or neurological symptoms. The test is crucial for families seeking answers about developmental concerns, as it can confirm a diagnosis, inform clinical management, and aid in family planning.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA sample to look for specific genetic alterations in the MBD5 gene that are known to cause MRD1. The process is meticulous, ensuring high accuracy and reliability in the results.
The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. For families affected by or at risk of MRD1, this test offers invaluable insights into the genetic underpinnings of the condition, enabling informed decisions about care and support.
The EPB41L1 gene plays a crucial role in cognitive development and brain function. Mutations in this gene have been linked to Mental Retardation, Autosomal Dominant Type 11, a condition characterized by intellectual disabilities and possibly other neurological or physical abnormalities. To diagnose this condition, a genetic test targeting the EPB41L1 gene can be conducted.
At DNA Labs UAE, individuals suspected of having Autosomal Dominant Type 11 Mental Retardation can undergo a specialized genetic test to detect mutations in the EPB41L1 gene. This test is a crucial step in confirming the diagnosis, which can then guide appropriate management and intervention strategies for the affected individuals and their families.
The cost of the EPB41L1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis of the gene to identify any mutations that may be responsible for the condition. Given the importance of accurate diagnosis for effective treatment and support, this test represents a valuable tool for individuals and families seeking answers about developmental and cognitive concerns.
The EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the EFTUD2 gene, which are linked to the rare genetic disorder known as Mandibulofacial Dysostosis with Microcephaly (MFDM). This condition is characterized by distinctive craniofacial features, microcephaly, and often other physical and developmental abnormalities. The test is crucial for accurate diagnosis, guiding treatment options, and providing essential information for genetic counseling.
Performed through a detailed analysis of the patient's DNA, this test seeks to detect specific genetic alterations in the EFTUD2 gene that are responsible for the development of MFDM. Early diagnosis through genetic testing can significantly benefit affected individuals and their families by enabling timely intervention and support services.
The cost of the EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive process of collecting a DNA sample, usually through a blood draw or cheek swab, conducting the genetic analysis, and providing a detailed report on the findings. The test is conducted with high precision and confidentiality, ensuring patients receive accurate and actionable results.
The PIEZO2 Gene Marden-Walker Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the PIEZO2 gene, which are associated with Marden-Walker Syndrome. Marden-Walker Syndrome is a rare congenital disorder characterized by multiple skeletal abnormalities, including a fixed facial expression, joint contractures, and a decrease in muscle tone. This condition is believed to be largely caused by mutations in the PIEZO2 gene, which plays a crucial role in the body's mechanical responses to stimuli.
The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to detect any mutations in the PIEZO2 gene. This test is crucial for families seeking a definitive diagnosis of Marden-Walker Syndrome, as it can guide treatment options and help in understanding the prognosis.
The cost of the PIEZO2 Gene Marden-Walker Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PIEZO2 gene. While the cost may be significant, the test offers invaluable insights for affected individuals and their families, aiding in the management and understanding of Marden-Walker Syndrome.
The L1CAM gene plays a crucial role in the nervous system's development, particularly in the brain and spinal cord. Mutations in the L1CAM gene are associated with MASA syndrome, a rare genetic disorder that affects the development of the nervous system, leading to a range of symptoms including intellectual disability, aphasia, shuffling gait, and adducted thumbs. MASA is an acronym for the key features of the syndrome: Mental retardation, Aphasia, Shuffling gait, and Adducted thumbs.
To diagnose MASA syndrome, genetic testing of the L1CAM gene is essential. DNA Labs UAE offers a comprehensive genetic test for the L1CAM gene to identify mutations that could indicate MASA syndrome. This test is crucial for families seeking answers to developmental delays and neurological symptoms in their children, providing them with a clear diagnosis and the possibility of genetic counseling.
The cost of the L1CAM gene MASA syndrome genetic test at DNA Labs UAE is 4400 AED. This test is conducted with the utmost confidentiality and accuracy, using state-of-the-art technology to ensure reliable results. Families and individuals opting for this test at DNA Labs UAE can expect professional guidance throughout the testing process, from sample collection to the interpretation of results.
The XK Gene McLeod syndrome with or without chronic granulomatous disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with McLeod syndrome, a rare condition that affects various systems in the body, including the nervous system, blood, and muscles. This syndrome can sometimes occur in conjunction with chronic granulomatous disease, an immune disorder that leads to recurrent infections and granuloma formation. The test specifically looks for abnormalities in the XK gene, which is crucial for the proper functioning of the Kx protein, involved in the development of these conditions. With a cost of 4400 AED, this genetic test is a critical tool for early diagnosis and management, helping healthcare providers to tailor appropriate treatment plans for affected individuals. By conducting this test at DNA Labs UAE, patients are ensured accurate, reliable results, leveraging state-of-the-art technology and expertise in genetic diagnostics.
The FLNA gene Melnick-Needles syndrome genetic test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FLNA gene, which are responsible for Melnick-Needles syndrome (MNS). MNS is a rare genetic disorder characterized by distinctive skeletal abnormalities, facial features, and other systemic involvements. The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can lead to the manifestations associated with MNS.
This genetic test involves analyzing the patient's DNA to identify mutations in the FLNA gene that are indicative of Melnick-Needles syndrome. Early diagnosis through this test can aid in the management and treatment of the syndrome, allowing healthcare providers to address symptoms more effectively and improve the quality of life for affected individuals.
The cost of the FLNA gene Melnick-Needles syndrome genetic test at DNA Labs UAE is 4400 AED. The test is conducted by experienced professionals who specialize in genetic diagnostics, ensuring accurate and reliable results. Patients seeking this test may require a referral from a healthcare provider, and it is recommended to discuss the potential benefits and implications of genetic testing with a genetic counselor or specialist prior to undergoing the test.
The "KLF8 Gene Mental Retardation Non-Syndromic Genetic Test" is a specialized diagnostic tool designed to identify mutations in the KLF8 gene, which have been associated with non-syndromic mental retardation. This condition is characterized by intellectual disabilities that occur without other significant physical or behavioral abnormalities. The KLF8 gene plays a crucial role in brain development and function, and mutations in this gene can lead to various neurodevelopmental disorders.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing techniques to detect any abnormalities or mutations in the KLF8 gene.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations and provide reliable results. This test is particularly valuable for families seeking a deeper understanding of intellectual disabilities with an unknown cause, as it can provide crucial information for diagnosis, management, and treatment planning.
The "NXF5 Gene Mental Retardation Non-Syndromic Genetic Test" is a specialized diagnostic tool designed to identify mutations in the NXF5 gene, which have been linked to non-syndromic mental retardation. This condition is characterized by intellectual disabilities that occur without additional physical or neurological symptoms typically associated with syndromic forms of mental retardation. The test is conducted by extracting a DNA sample from the patient, which is then analyzed in a laboratory setting to detect any abnormalities or mutations in the NXF5 gene that could be responsible for the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for families seeking to understand the genetic basis of intellectual disabilities in their loved ones. It can provide essential information for making informed decisions about care, support, and potential therapies. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed reporting that accompanies this advanced genetic assessment. By identifying specific genetic mutations, the test not only aids in the diagnosis of non-syndromic mental retardation but also contributes to a broader understanding of the genetic factors involved in intellectual disabilities.
